RxDoctor Payments Data

Steven Leonowicz, DO

Family Medicine · Clinton Township, MINPI 1497378301

Payments from drug & device makers

$1,540in general payments, 2019–2025

Across 59 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$329
  • Novo Nordisk$246
  • Johnson & Johnson$219
  • Exact Sciences$121
  • Lilly USA, LLC$121
  • Sanofi$94
  • plus $410 from 10 others

What the payments were for

  • Food & beverage$1,540100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,540 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$27,839
Medicare patients
98
Services billed
438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$18,471
JardianceEmpagliflozin11$16,544
Atorvastatin Calcium38$541
Albuterol Sulfate HfaAlbuterol Sulfate16$477
Fluticasone Propionate46$397
Losartan Potassium23$338
Allopurinol11$333
Metoprolol Succinate23$330
Omeprazole24$271
Gabapentin17$264
Amlodipine Besylate35$238
Rosuvastatin Calcium17$230
Azelastine Hcl13$225
Pantoprazole Sodium20$215
Lisinopril23$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$30$18,47123 claims
Boehringer IngelheimJardiance$84$16,54411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Clinton Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →